INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

LOS ANGELES CAPITAL MANAGEMENT LLC's Holding History (CIK: 0001177206)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021
Shares 42,049 Value ($000) $624 Avg Close Range
Q2 2021
Shares 44,259 Value ($000) $884 Avg Close Range
Q1 2021
Shares 27,753 Value ($000) $641 Avg Close Range
Q4 2020
Shares 40,017 Value ($000) $988 Avg Close Range
Q3 2020
Shares 15,730 Value ($000) $652 Avg Close Range
Q2 2020
Shares 20,719 Value ($000) $993 Avg Close Range
Q1 2020
Shares 14,980 Value ($000) $943 Avg Close Range
Q4 2019
Shares 14,980 Value ($000) $1,856 Avg Close Range
Q3 2019
Shares 7,400 Value ($000) $491 Avg Close Range
Q2 2019
Shares 3,047 Value ($000) $242 Avg Close Range
Q1 2019
Shares 3,067 Value ($000) $343 Avg Close Range
Q2 2014
Shares 2,877 Value ($000) $681 Avg Close Range